Session 2 – What’s Hot in EP
Does Time to Therapy Matter in Atrial Fibrillation: Results from EAST-AFNET 4 Trial
Oussama Wazni, MD, FACC

Emerging Therapies for Persistent Atrial Fibrillation: Hybrid Ablation
Anish Amin, MD

Moderator: Devi Nair, MD, FACC

Session 3 – Possibilities & Controversies in IC
Transcatheter Tricuspid Valve Intervention (TTVI) and Clinical Outcomes
Rebecca T. Hahn, MD, FACC

ISCHEMIA: The Ongoing Debate – an IC vs Cardiology Perspective
Thura Harfi, MD and Steven J. Yakubov, MD, FACC

Moderator: Timothy Smith, MD, FACC

2021 Carl J. Wiggers Memorial Lecture
Residual Cardiovascular Risk in Statin-Treated Patients with Elevated Triglycerides: Now We Can REDUCE-IT
Deepak L. Bhatt MD, MPH, FACC, FAHA, FSCAI, FESC

Moderator: Joseph F. Pietrolungo, DO, MS, FSVM, FACC

Syllabus

In support of improving patient care, this activity has been planned and implemented by the American College of Cardiology Foundation and the Ohio Chapter of the American College of Cardiology. The American College of Cardiology Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
The ACCF designates this live educational activity for a maximum of 3.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nurses
The ACCF designates this live educational activity for a maximum of 3.25 continuing nursing education contact hours (2.50 pharmacotherapeutic nursing contact hours).  Each attendee should only claim credits commensurate with the extent of their participation in the activity.

Pharmacists
ACCF designates this continuing education activity for 3.25 contact hours (0.325 CEUs) of the Accreditation Council for Pharmacy Education.

While offering credits noted above, the course is not intended to provide extensive training or certification in this field.

Statement of Need
Cardiovascular care is rapidly evolving with new technologies. Healthcare providers need periodic educational updates on emerging clinical trials and advances in patient management. They need to learn from case scenarios applicable to daily practice and gain knowledge of changes to practice guidelines, so they can apply evidence-based research to their patient management decisions.

Overall Goal
The overall goal of this activity is to increase learner competence by discovering strategies to anticipate research-driven changes in practice, to enhance professional growth, and to demonstrate efficacy in patient care practice as new clinical approaches and technologies change.

Learner Objectives

• Employ latest advancements in the management of the heart failure patient.
• Compare and contrast the most current treatment strategies for atrial fibrillation.
• Identify strategies to treat patients with SIHD.
• Describe the results of icosapent ethyl in REDUCE-IT and discuss the role of elevated triglycerides as a risk factor.

Target Audience
Adult Cardiologists, Pediatric Cardiologists, Cardiothoracic Surgeons, Cardiology Fellows-in-Training, Nurses, Nurse Practitioners, Clinical Nurse Specialists, Physician Assistants, Pharmacists

Disclosure Policy
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC), the American College of Cardiology Foundation (ACCF) must ensure balance, independence, objectivity and scientific rigor in all of their directly provided or jointly provided/co-provided educational activities. Planners, presenters, and other contributors, in a position to control the content are required to disclose to the audience all relevant financial relationships he/she and/or his/her spouse or domestic partner may have, occurring within the past 12 months, with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. When an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, the contributor should disclose that the product is not labeled for the use under discussion or that the product is still investigational.

ACCF is committed to providing its learners with high-quality activities and materials that promote improvements and quality in health care and not a specific proprietary business or commercial interest. The intent of this disclosure is not to prevent participation in educational activities by persons with a financial or other relationship, but rather to provide learners with information on which they can make their own determination whether financial interests or relationships may influence the education activity.

ACCF assesses conflicts of interest (COI) with its faculty, planners, managers, staff and other individuals who are in a position to control the content of CME/CNE activities. All relevant potential conflicts of interest that are identified are thoroughly vetted through a process that includes course directors and appropriate peer review by education committee chairs/members, for fair balance, scientific objectivity and validity, and patient care and safety recommendations.